Skip to Content

CAP 150 (Capecitabine 150 mg)

Pill with imprint CAP 150 is Pink, Capsule-shape and has been identified as Capecitabine 150 mg. It is supplied by Shilpa Medicare Limited.

Capecitabine is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer; non-small cell lung cancer; pancreatic cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CAP 150

Capecitabine

Imprint:
CAP 150
Strength:
150 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Shilpa Medicare Limited
National Drug Code (NDC):
63759-3000

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide